Clinical trial
The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for…
NCT00498121 · McGill University Health Centre/Research Institute of the McGill University Health Centre, Other · Terminated
Key facts
| NCT number | NCT00498121 |
|---|---|
| Title | The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP) |
| Official title | The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP) |
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Ventilator Associated Pneumonia |
| Intervention type | Device |
| Interventions | PROCALCITONIN LEVEL |
| Enrollment | 50 |
| Start date | Jul 1, 2007 |
| Completion | May 1, 2009 |
| First posted | Jul 9, 2007 |
| Last update posted | Dec 18, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: